If you need more lookups,
subscriptions start at $34 USD/month.
Catherine Martre Location
Paris, FR
Catherine Martre Work
General Manager @ (July 2025 - Present)
Board Member @ (September 2024 - Present)
CEO @ (January 2021 - June 2025)
Head of global Market Access @ (January 2019 - December 2020)
Head of Commercial Operations France and Market Access Europe @ (January 2016 - January 2019)
International Strategy and commercial development Director @ (January 2013 - January 2016)
Non executive board member, strategic committee @ (January 2016 - January 2019)
Strategy and Public Affairs Director @ (January 2011 - January 2013)
Integration Officer Nycomed and Takeda @ (January 2011 - January 2012)
Strategy and Business Support Director @ Nycomed (January 2009 - January 2011)
Strategy and Market Research Manager @ Nycomed (January 2007 - January 2009)
Market research manager @ (January 2001 - January 2007)
Consultant @ (January 1997 - January 2001)
Catherine Martre Education
CentraleSupélec
Post Graduate Degree
1995-1996
Centrale Nantes
Master in Science (MS) (Engineering)
1993-1996
Catherine Martre Skills
Pharmaceutical Industry
Strategy
Biotechnology
Market Access
Management
Strategic Planning
Business Development
Project Management
Cross-functional Team Leadership
Market Research
Pricing Strategy
Reimbursement
Public Affairs
Leadership
Product launch
Life sciences
sales effectiveness
Sciences de la vie
Cross Functional Team Leadership
Lancement de produit
Catherine Martre Summary
Catherine Martre, based in Paris, FR, is currently a General Manager at France Biotech. Catherine Martre brings experience from previous roles at Altevax Biotech, Meletios Therapeutics and Advicenne Pharma SA. Catherine Martre holds a 1995 - 1996 Post Graduate Degree @ CentraleSupélec. With a robust skill set that includes Pharmaceutical Industry, Strategy, Biotechnology, Market Access, Management and more. Catherine Martre has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Catherine Martre?
Find contact details for 700 million professionals.